Travere Therapeutics CFO Cline Christopher R. exercised Options for 20,000 shares at $17.44 per share and sold 50,508 shares across four transactions on 2026-09-15. The reported prices and resulting holdings give investors the transaction size, sale range and ownership changes tied to the activity.

Key Highlights

  • Cline Christopher R. exercised options for 20,000 Travere Therapeutics shares at $17.44 per share.
  • Four sales covered 50,508 shares at prices ranging from $62.00 to $65.31 per share.
  • Cline’s derivative securities holding fell to 0 after the option exercise, representing 100.0% of his prior holding.

Travere Therapeutics, Inc. (NASDAQ: TVTX) is a Pharmaceuticals: Major company. Cline Christopher R. its CHIEF FINANCIAL OFFICER, exercised options covering 20,000 shares at $17.44 per share on 15 September 2026. The exercise left him with 138,016 shares, representing about 14.5% of his resulting share holding. Cline also sold a total of 50,508 Travere Therapeutics shares through four separate transactions on the same date. The sale prices ran from $62.00 to $65.31 per share. Those sales left Cline with 87,508 shares. The sales represented about 36.6% of his prior share holding.

Derivative Securities Holding Reaches Zero

The option exercise covered 20,000 derivative securities. After that transaction, Cline held 0 derivative securities, equal to about 100.0% of his prior derivative securities holding.